Welcome to our dedicated page for NATIONAL HEALTHCARE SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NATIONAL HEALTHCARE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NATIONAL HEALTHCARE's regulatory disclosures and financial reporting.
National HealthCare Corporation reports that First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly reported beneficial ownership of 795,771 shares of National HealthCare common stock, representing 5.09% of the class as of June 30, 2026.
The reporting persons show no sole voting or dispositive power, with shared voting power over 780,661 shares and shared dispositive power over 795,771 shares. The holdings are primarily in unit investment trusts and other investment vehicles for which First Trust entities act as sponsor or advisor. Voting of the unit investment trust shares is carried out by the trustee, and the reporting entities disclaim beneficial ownership of the reported shares.
National HealthCare Corporation completed a major real estate transaction by acquiring from National Health Investors the land and buildings for 32 skilled nursing facilities and three independent living facilities it had long leased, for a $560 million cash purchase price.
The company funded the deal with borrowings under its new Credit Agreement, drawing $475 million from a senior unsecured term loan and $55 million from its senior unsecured revolving credit facility, plus cash on hand. It simultaneously increased the revolver capacity from $50 million to $75 million and terminated commitments under a prior 2024 credit facility that had no outstanding borrowings.
A Partial Master Lease Termination Agreement ended the master lease for all acquired facilities except four Florida skilled nursing facilities, where a third-party operator’s lease continues and the master lease for those properties was assigned to an NHC subsidiary. NHC states that owning these properties, located across seven states, aligns with its strategy and is expected to be accretive to earnings, cash flow, and long-term investor returns.
National Healthcare Corp director HASSAN EMIL E reported an open-market sale of 5,937 shares of common stock at $200.00 per share on June 22, 2026, and now directly holds 65,595 shares.
The director also holds multiple stock option grants, each covering 7,500 underlying common shares, with exercise prices ranging from $55.75 to $171.42 and expiration dates from 2027 through 2031. These options represent ongoing equity-based compensation rather than new purchases or sales.
National Healthcare Corp’s SVP and CFO, Brian F. Kidd, reported a Form 4 showing a bona fide gift of 500 shares of common stock at $0.00 per share, leaving him with 29,996 common shares held directly.
The filing also details his outstanding stock options on common stock, including 14,000 underlying shares at $157.13 expiring on February 23, 2031, 9,000 shares at $90.62 expiring on February 24, 2030, 4,000 shares at $94.10 expiring on March 5, 2029, and 4,147 shares at $53.94 expiring on March 8, 2028.
NATIONAL HEALTHCARE CORP director Emil E. Hassan reported an open-market sale of 1,563 shares of common stock at $199.975 per share. After this transaction, he directly holds 71,532 shares. He also retains several stock option awards, each covering 7,500 underlying shares from 2022–2026 grants with exercise prices between $55.75 and $171.42 and expirations from 2027 to 2031.
National Healthcare Corp director Robert G. Adams reported routine equity movements involving company stock and options. On 2026-06-08, a trust for which he serves as trustee exercised options to acquire 4,000 shares of common stock at $69.19 per share, and that same trust made a bona fide gift of 4,000 shares at no stated price.
Separate entries list his indirect partnership holdings of 430,341 shares and show that, after these transactions, the trust holds 13,579 shares. He also continues to hold multiple stock option grants directly, each covering 7,500 underlying shares with exercise prices between $55.75 and $171.42 and expirations from 2028 to 2031. The filing reflects exercises, gifts, and existing holdings rather than open-market buying or selling.
NATIONAL HEALTHCARE CORP director Lisa Piercey reported an open‑market purchase of 949 shares of Common Stock at $184.2559 per share. Following this transaction, she holds 949 Common shares directly. The filing also lists a 2026 stock option grant covering 7,500 underlying Common shares at a $171.42 exercise price, expiring on May 6, 2031, with a corrected expiration date noted for this option award.
National HealthCare Corporation entered into a new Credit Agreement providing a $475.0 million senior unsecured term loan and a $50.0 million senior unsecured revolving credit facility. The term loan is intended to finance part of the purchase price for NHC’s previously announced acquisition of assets and real property from National Health Investors and affiliates.
The company expects to draw the full $475.0 million term loan, and may draw on the revolver at closing, currently anticipated on or around July 1, 2026, in the third quarter of 2026. The facilities mature five years after initial funding, with the term loan amortizing in quarterly installments of about $5.9 million and the revolver requiring interest-only payments.
Interest is based on Term SOFR or a base rate plus a margin that varies with NHC’s consolidated leverage ratio, initially set at Term SOFR + 1.50% or base rate + 0.50%. The agreement replaces NHC’s existing undrawn credit facility and includes customary financial covenants, events of default, and lender remedies. Commitments terminate automatically if the transaction is not completed or funded by August 31, 2026.
NATIONAL HEALTHCARE CORP Senior VP & CIO Ben Anderson Flatt Sr reported compensation-related stock option activity. He exercised 4,000 options at an exercise price of $94.10 per share, receiving the same number of common shares.
The company withheld 2,739 common shares at $196.00 per share to cover the option exercise price and withholding tax obligations. Following these transactions, he directly beneficially owns about 22,636 common shares, and continues to hold stock options linked to 14,000 shares at $157.13 and 9,000 shares at $90.62 with expirations in 2031 and 2030, respectively.
NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. reported an open-market sale of 7,500 shares of common stock at $195.1421 per share. After this sale, he directly holds 205,760 common shares, indicating he retains a substantial equity position.
In addition to these shares, he holds multiple option awards covering 7,500 underlying shares each from grants dated 2022 through 2026, with exercise prices ranging from $55.75 to $171.42 and expirations between 2027 and 2031. No derivative options were exercised in this filing.